Clinical Trial Update: Trabectedin Maintenance Post 1st-line in STS [Phase 3]

View source ↗

Summary

Phase 3 trial update on trabectedin maintenance after first-line therapy in soft tissue sarcoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Trabectedin (trabectedin)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Sarcoma, Soft Tissue | Phase 3 | Status: TERMINATED